Evidence map›Paper›PMID 41567832›Full record

ArticleAmerican journal of nuclear medicine and molecular imaging2025

Quantification of I-131 thyroid remnant uptake in patients with thyroid cancer.

Elaheh Amini, Catherine Kim, Asya S Al-Busaidi, Ran Klein, Wanzhen Zeng

Abstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in American journal of nuclear medicine and molecular imaging, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors.

Elaheh AminiSystems and Computer Engineering, Carleton University Ottawa, Ontario, Canada.
Catherine KimFaculty of Medicine, University of Ottawa Ottawa, Ontario, Canada.
Asya S Al-BusaidiDepartment of Radiology and Nuclear Medicine, Sultan Qaboos Comprehensive Cancer Care and Research Centre, University Medical City Muscat, Oman.
Ran KleinSystems and Computer Engineering, Carleton University Ottawa, Ontario, Canada.
Wanzhen ZengDivision of Nuclear Medicine and Molecular Imaging, Faculty of Medicine, University of Ottawa Ottawa, Ontario, Canada.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Radioiodine ablation is commonly performed after thyroidectomy for well-differentiated thyroid cancer (DTC). This study aimed to quantify thyroid remnant uptake in standardized uptake values (SUV) and evaluate its correlation with post-therapy Thyroglobulin (Tg) levels across different risk groups. We retrospectively quantified SUV uptake with attenuation, scatter, and resolution recovery corrections on post-therapy SPECT/CT in thyroid cancer patients referred to our centre between 2015 and 2017. Thyroid remnant was segmented with a maximum SUV of 0.5 as the threshold and total thyroid remnant uptake (SUV

Indexed as

radioiodine ablation therapySingle-photon emission computed tomography (SPECT)/CTstandard uptake value (SUV)Thyroid cancerthyroid remnant quantification

Identifiers

PMID41567832
PMCPMC12816826

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.